Adial Pharmaceuticals, Inc. (ADIL) vs Phio Pharmaceuticals Corp. (PHIO)
A side-by-side comparison of Adial Pharmaceuticals, Inc. and Phio Pharmaceuticals Corp. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ADIL
Adial Pharmaceuticals, Inc.
$4.16HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
PHIO
Phio Pharmaceuticals Corp.
$1.00HealthcareDelayed quote: Oct 6, 2026, 3:28 PM EDT
Total return — ADIL vs PHIO
growth of $100 · dividends reinvested · last 8yADIL -99.8% (-54.9%/yr)PHIO -100.0% (-68.5%/yr)ADIL compounded faster over this window
Log scale — wide-divergence pair
ADIL PHIO
ADIL vs PHIO: by the numbers
- •PHIO is the larger company ($12M vs $11M market cap).
Metrics side by side
Valuation
| Metric | ADIL | PHIO |
|---|---|---|
| P/B ratio | N/A | 0.92 |
Profitability
| Metric | ADIL | PHIO |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -37052.06% | -102.40% |
| ROIC | -240.64% | -100.51% |
Growth (annualized)
| Metric | ADIL | PHIO |
|---|---|---|
| Total return CAGR (5Y) | -71.86% | -65.73% |
Frequently asked
- How have ADIL and PHIO total returns compared?
- Over the past 5 years, ADIL delivered -71.86% and PHIO delivered -65.73% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.